Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations

Pre-exposure prophylaxis (PrEP) with oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) prevented HIV acquisition among men and women in several trials and is broadly recommended. In the VOICE and FEM-PrEP trials, however, TDF/FTC-based PrEP did not prevent HIV acquisition among women in e...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:AIDS Res Hum Retroviruses
Główni autorzy: Koss, Catherine A., Bacchetti, Peter, Hillier, Sharon L., Livant, Edward, Horng, Howard, Mgodi, Nyaradzo, Mirembe, Brenda G., Gomez Feliciano, Kailazarid, Horn, Stephanie, Liu, Albert Y., Glidden, David V., Grant, Robert M., Benet, Leslie Z., Louie, Alexander, van der Straten, Ariane, Chirenje, Z. Mike, Marrazzo, Jeanne M., Gandhi, Monica
Format: Artigo
Język:Inglês
Wydane: Mary Ann Liebert, Inc. 2017
Hasła przedmiotowe:
PrEP
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564054/
https://ncbi.nlm.nih.gov/pubmed/28253024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0202
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy